Portal de Periódicos da CAPES

Immunomodulating peptides of natural and synthetic origin

1991; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês

10.1002/med.2610110106

1098-1128

Vassil St. Georgiev,

Immune Response and Inflammation

Medicinal Research ReviewsVolume 11, Issue 1 p. 81-119 Article Immunomodulating peptides of natural and synthetic origin Vassil St. Georgiev, Vassil St. Georgiev Division of Life Sciences, Orion Research & Technologies Corp., P.O. Box 463, Tampa, Florida 33601-0463 Vassil St. Georgiev: earned his advanced degree in chemistry from the Institute of Organic Chemistry at the Bulgarian Academy of Sciences in 1971. During 1971–1972 he was an UNESCO Visiting Scientist at University of Delhi, India, and from 1972 until 1975 he was a Senior Research Scientist at the Department of Chemistry, Pennsylvania State University. In 1975 he joined the Research Department of Revlon Health Care Group where he worked in the areas of inflammation and allergy/immunology. In 1980 he went to work for Pennwalt Pharmaceutical Division in Rochester, NY (recently acquired by Fisons Pharmaceuticals) where he was a Senior Principal Investigator and Section Head of Immunologic, Infectious, and Metabolic Diseases Research at the Department of Organic Chemistry. Presently, he is Vice President at Orion Research & Technologies Corp. in Tampa, FL.Search for more papers by this author Vassil St. Georgiev, Vassil St. Georgiev Division of Life Sciences, Orion Research & Technologies Corp., P.O. Box 463, Tampa, Florida 33601-0463 Vassil St. Georgiev: earned his advanced degree in chemistry from the Institute of Organic Chemistry at the Bulgarian Academy of Sciences in 1971. During 1971–1972 he was an UNESCO Visiting Scientist at University of Delhi, India, and from 1972 until 1975 he was a Senior Research Scientist at the Department of Chemistry, Pennsylvania State University. In 1975 he joined the Research Department of Revlon Health Care Group where he worked in the areas of inflammation and allergy/immunology. In 1980 he went to work for Pennwalt Pharmaceutical Division in Rochester, NY (recently acquired by Fisons Pharmaceuticals) where he was a Senior Principal Investigator and Section Head of Immunologic, Infectious, and Metabolic Diseases Research at the Department of Organic Chemistry. Presently, he is Vice President at Orion Research & Technologies Corp. in Tampa, FL.Search for more papers by this author First published: January 1991 https://doi.org/10.1002/med.2610110106Citations: 14 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume11, Issue1January 1991Pages 81-119 RelatedInformation